Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00892788 · ClinicalTrials.gov registry record · NA

A Behavioral Intervention for Reducing Obesity

A NA study, sponsored by UConn Health.

Completed
Registry status
NA
Development phase
56
Enrollment target

NCT00892788: Completed NA study, sponsored by UConn Health.

NCT00892788 is a NA study that has completed, run by UConn Health. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00892788, a NA study, has completed, sponsored by UConn Health.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target

Study Summary

This study will examine a contingency management (CM) intervention designed to provide incentives for losing weight versus participating in a manual-guided behavioral weight loss intervention alone. Participants in the CM condition will earn the opportunity to win prizes by losing weight and completing activities that contribute to weight loss, such as keeping daily food and physical activity diaries, choosing healthy foods, exercising, and using other weight loss strategies. The investigators will determine if the CM improves weight loss relative to the usual care manual-guided intervention alone.

Interventions

  • BEHAVIORAL contingency management
  • BEHAVIORAL weight loss manual-guided individual therapy sessions

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2009-04
Est. Completion 2010-07
Phase NA
UConn Health

178 total trials

What the finished NCT00892788 record still lists

NCT00892788 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which contingency management is the first listed.

NCT00892788 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00892788 about?

NCT00892788 is a clinical study titled "A Behavioral Intervention for Reducing Obesity". This study will examine a contingency management (CM) intervention designed to provide incentives for losing weight versus participating in a manual-guided behavioral weight loss intervention alone. Participants in the CM condition will earn the opportunity to win prizes by losing weight and complet...

What is the current status of trial NCT00892788?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2009-04. Estimated completion is 2010-07.

What interventions are being tested in trial NCT00892788?

The interventions under investigation include: contingency management (BEHAVIORAL), weight loss manual-guided individual therapy sessions (BEHAVIORAL).

Who is sponsoring clinical trial NCT00892788?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00892788's enrollment target sits among peer trials

56 1262nd of 2000 higher than 737 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00892788, the US trial registry maintained by the National Library of Medicine. NCT00892788 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.